844-436-7691
Written by Marc Brannigan, Co-Founder & CEO of HempMy Pet. Last updated 15 October 2026.
The short answer: TB-500 is a synthetic fragment of thymosin beta-4, a tissue-repair protein. It works on cell migration and collagen production, which makes it the more targeted choice for tendon and ligament injury, and it is almost always paired with BPC-157 rather than used alone. Its evidence is cell and animal data plus racehorse-trainer experience; there is no controlled trial in dogs. Same cancer caution as BPC-157, same legal route (a vet-ordered compounded preparation), same stop for any dog with a mass.
TB-500 gets less search traffic than BPC-157 and more confusion, because almost nobody uses it by itself. This is what it does, where it came from, how it differs from BPC-157, and the dogs it should never go into.
What TB-500 Actually Does
Thymosin beta-4 is a 43-amino-acid protein present in nearly every mammalian cell; TB-500 is a synthetic fragment of it. Its best-described job is regulating actin, part of the internal scaffolding cells use to move. Cell migration is the unglamorous first step of any repair: fibroblasts and other repair cells have to physically travel to damaged tissue before anything is rebuilt. TB-500 also stimulates tenocyte proliferation and collagen production, and promotes new blood-vessel growth.
Its reputation was built in racehorses, where thymosin beta-4 has been used for flexor-tendon and suspensory-ligament injuries for years — racing bodies test for it. That equine history is where the canine use came from. The canine evidence itself is thinner than BPC-157's: there is no dog pharmacokinetic study, no dog safety study, and no controlled trial.
TB-500 vs BPC-157
| BPC-157 | TB-500 | |
|---|---|---|
| What it is | 15-amino-acid peptide from a gastric protein | Fragment of thymosin beta-4, a tissue-repair protein |
| Mechanism | Angiogenesis, growth-factor signalling, nitric-oxide modulation | Actin regulation, cell migration, collagen and tenocyte production |
| Best for | Joints, soft tissue, post-surgical, gut | Tendon and ligament injury, muscle tears |
| Route | Subcutaneous; oral for gut | Subcutaneous only |
| Frequency | Daily | Twice weekly loading, then weekly |
| Dog data | One PK study, one 28-day safety study, case series | None published; case series and equine extrapolation |
| Cost | Lower | Higher; stacking roughly doubles the peptide cost |
Because the two act on different pathways there is no redundancy in combining them, which is why the pairing — the "Wolverine stack" in human circles — is the standard approach in sport-dog practice for a partial cruciate tear or a significant tendon injury. For an owner, the practical point is that TB-500 is rarely the first question. If your dog is a candidate for anything, the vet usually starts with BPC-157 and adds TB-500 for a defined soft-tissue injury.
Who Is a Candidate
A dog with a diagnosed tendon or ligament injury — partial cruciate tear, iliopsoas strain, biceps tendinopathy, a post-surgical repair — whose vet is willing to prescribe and monitor. Not a stiff senior with worn joints (that is a comfort problem, and TB-500 adds cost without a tendon to target). Not a dog with a lump. Not a dog whose limp has not been worked up: nine things cause a limp and a repair peptide fixes none of the other eight.
Is your dog a candidate for a BPC-157 + TB-500 protocol?
A diagnosed tendon or ligament injury, a partial cruciate tear, or a post-surgical repair — tell us the dog, the diagnosis and what the dog is taking, and a vet on our team will review it.
Got it — thank you.
We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.
Safety
The caution that matters most: cancer. BPC-157 and TB-500 work partly by growing new blood vessels, and a tumour needs new blood vessels to grow. No study has shown either peptide causes or accelerates cancer in a dog — and most vets who use them still refuse to give them to any dog with a known or suspected mass. The AVMA puts the lifetime risk at about 1 in 4 dogs, rising to 1 in 2 for dogs 10 and older, which is exactly the senior population these are marketed to. A new lump, unexplained weight loss or a sudden decline is a stop-and-get-it-checked, not a reason to start a peptide.
TB-500 specifically: because it is given less often and persists longer in tissue, a reaction cannot be stopped by simply skipping the next dose. There is no interaction data with NSAIDs, gabapentin, Librela or steroids. The NAVC's chief veterinary officer told Forbes this week that some peptides marketed to pet owners have barely been through safety studies.
Legality, briefly. There is no FDA-approved BPC-157, TB-500 or KPV product for animals. The lawful route is a licensed veterinarian ordering a compounded preparation under FDA's Guidance for Industry #256, which covers non-food animals, on a vet's order, when no approved option works. FDA's advisory committee voted 8–6 in July 2026 to recommend BPC-157, KPV, TB-500 and MOTS-c for human compounding; the vote is not binding and FDA has not acted. A research-only vial bought online and injected without a vet sits outside all of it. The full timeline is in Peptides for Dogs.
Cost
TB-500 is the more expensive of the pair. A vet-supervised 8-week BPC-157 or TB-500 course is typically quoted at $300–800 including consultations, and running both roughly doubles the peptide cost. Compare that against TPLO surgery at $3,000–6,000, which has far stronger outcome data for a ruptured cruciate and is the procedure peptides are used around, not instead of.
The recovery-window comfort layer — legal, oral, with canine trial data
250mg Hemp Seed Oil Small dogs · by the drop $49 
1,000mg Hemp Seed Oil Medium and large dogs $99 
Large Dog Hemp Treats 5mg each · easiest daily option $32 Grown on our own certified-organic Colorado farm, formulated in-house, third-party tested every batch. Serving by weight →
If your dog takes any prescription medication, talk to your vet before adding hemp, because it can change how quickly the body clears other drugs. We cover that, and the published safety findings, in hemp and CBD side effects in dogs.
Where Hemp Fits
Hemp has nothing to offer a torn tendon structurally. What it does is make the recovery window more tolerable — a dog that is more comfortable rests better and tolerates confinement better — and it is the daily layer most of these dogs stay on after the protocol ends. Oral, legal, $49–99 a bottle, five canine arthritis trials. We lay the two side by side in Peptides vs CBD for Dogs.
Frequently Asked Questions
What exactly does TB-500 do?
It is a synthetic fragment of thymosin beta-4 that regulates actin — the scaffolding cells use to move — so repair cells migrate to damaged tissue faster. It also stimulates tenocyte proliferation, collagen production and new blood-vessel growth. In practice that makes it the more targeted choice for tendon and ligament injury, usually alongside BPC-157.
What peptides are safe for dogs?
None has a controlled safety trial in dogs. BPC-157 has a 28-day beagle study with no apparent changes and a pharmacokinetic study reporting good tolerance; TB-500 has neither. Oral collagen peptides — a food-grade product — are the only 'peptide' with a controlled canine trial. Safety in a specific dog is a vet's call, and the cancer caution applies to every angiogenic peptide.
Is BPC-157 safe for dogs with arthritis?
It is the most common reason owners try it, and a decade of case series report no serious adverse events. But there is no controlled trial, and an arthritic senior is exactly the dog most likely to have an undiagnosed mass — about 1 in 2 dogs over 10 develops cancer. A vet check for lumps comes first. For plain joint comfort, hemp has the trial data and none of the injection or legality issues.
Can dogs take BPC-157 and TB-500 together?
That is how they are usually used — the pairing is standard in sport-dog practice for soft-tissue injury because the two act on different pathways. It should be a vet's protocol, not two vials bought separately online, and stacking roughly doubles the cost.
How is TB-500 given to dogs?
Subcutaneous injection, typically twice weekly during a loading phase and then weekly, for four to six weeks. Doses are weight-based and set by the prescriber; we do not publish a chart.
What is the silent killer of dogs?
Usually cancer, bloat, heart disease or kidney disease — conditions that advance without obvious signs. It matters for TB-500 because the peptide promotes blood-vessel growth, so a senior with an unexplained decline needs a cancer workup before any angiogenic peptide, not after.
Is TB-500 legal for dogs?
Not as an approved product. A licensed vet may order a compounded preparation under FDA's animal-compounding guidance; a research-only vial injected without a vet is outside that. FDA's advisory committee voted in July 2026 to recommend TB-500 for human compounding, but the vote is non-binding and does not create a veterinary product.
How long does TB-500 take to work in dogs?
Soft-tissue injuries are reported to show measurable progress at three to four weeks, with most protocols running four to six. If nothing has changed by six weeks, the diagnosis should be revisited rather than the dose increased.
Not sure TB-500 is even the right question?
Most dogs that end up here are better served by something simpler. Two minutes, and a vet tells you which.
Got it — thank you.
We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.
Marc co-founded HempMy Pet in 2016 with his business partner Natalie Mondine, the company's COO. They were making the hemp oil for people first and bottled it for pets — one of the first CBD products made for pets. HempMy Pet breeds its own hemp genetics, grows them on its certified-organic Colorado farm, and formulates every batch in-house under human-grade standards — seed to sale, nothing sourced overseas. Every batch is third-party tested and the certificates of analysis are published. More about us.
HempMy Pet ran its own 90-day study of 37 dogs with chronic joint discomfort. Of the 32 that completed it, 30 (93%) showed a benefit, and 94% of owners reported their dog's quality of life had improved. It was overseen by Dr. Robin Downing, DVM, MS of the Downing Center for Animal Pain Management, with Lori Kogan, Ph.D. and Peter W. Hellyer, DVM of Colorado State University's College of Veterinary Medicine & Biomedical Sciences, and published in the Journal of the American Holistic Veterinary Medical Association. Read the methodology.
Why Dr. Downing: in 2005 she became only the third veterinarian in the world credentialed as a Diplomate of the American Academy of Pain Management. She founded the International Veterinary Academy of Pain Management, is a Diplomate of the ACVSMR, a Certified Veterinary Pain Practitioner and a Certified Canine Rehabilitation Practitioner, and was the AVMA's 2020 Bustad Companion Animal Veterinarian of the Year. Chronic joint pain is her life's work. Read the published paper (PDF).
This article is general information for dog owners, not veterinary advice. It is reviewed and updated as new peer-reviewed evidence is published, and where the evidence is thin or negative we say so.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is general information, not veterinary advice. If your dog is unwell, contact your veterinarian.
